Healthcare // Browsing posts in Healthcare
ICD and CRT Premature Battery Depletion Idea Proposal (MDT, STJ)
Are manufacturers of ICDs and CRTs at risk for major product recalls due to Premature Battery Depletion? Report Available: March 15, 2017 Blueshift’s initial research, in conjunction with Pharm3r software solutions, reveals a pattern of Premature Battery Depletion for several ICD and CRT devices that is consistent with other ICDs and CRTs that have […]
Steady Growth Trend Continues for the Dental Market (XRAY)
Research Question: What are the current dental industry market conditions? Companies: ALGN, HSIC, PDCO, WEB, XRAY By: David Franklin Click here to download report (.pdf) Summary of Findings In a follow-up to Blueshift Research’s 15 report on Dentsply Sirona Inc. (XRAY), dental market conditions continue to fluctuate, but they have improved for all five […]
Steady Adoption Growth Expected for Dentsply Sirona’s CEREC (XRAY)
Research Question: Will Dentsply Sirona’s merger lead to accelerated adoption of its CEREC CAD/CAM system? Companies: ALGN, HPE, HSIC, MMM, PDCO, XRAY By: David Franklin Click here to download report (.pdf) Summary of Findings Dentsply Sirona Inc. (XRAY) will see steady growth in the adoption of its CEREC system, according to 14 of 18 dentists, […]
HEDIS Will Create Modest Growth for Exact Sciences’ Cologuard (EXAS)
Research Question: Will the inclusion of Cologuard in the 2017 HEDIS quality measures drive growth for Exact Sciences? Companies: DGX, EPGNF, EXAS, GE, LH, SIEGY, TYO:6502 By: David Franklin Click here to download report (.pdf) Summary of Findings The inclusion and equal footing of Exact Sciences Corp.’s (EXAS) Cologuard in the 2017 Healthcare Effectiveness Data […]
Dentsply Sirona Idea Proposal
Will the Dentsply Sirona merger lead to accelerated adoption of its CEREC CAD/CAM system? Report Available: September 15, 2016 Blueshift’s initial research found Dentsply’s recently completed merger with Sirona creating an opportunity for increased adoption of the CEREC system and a continued shift to digital dentistry and single-visit dentistry. However, film X-rays are still […]
Exact Sciences Idea Proposal (EXAS)
Will the inclusion of Cologuard in the 2017 HEDIS quality measures drive growth for Exact Sciences? Report Available:August 31, 2016 Blueshift’s initial research shows that momentum for Cologuard, EXAS’s colon cancer screening test, has picked up recently as a governing body clarified language that the test is on equal standing among other screening tests, […]
NVDQ’s DermACELL On Track to Achieve 2016 Sales Goal of $10 Million
Research Question: Will Novadaq grow DermACELL sales to $10 million in 2016 and $50 million or more by 2018? Companies: AGN, IART, JNJ, MDXG, NVDQ, NVS, OSIR By: David Franklin Click here to download the report (.pdf) Summary of Findings DermACELL, an acellular dermal matrix (ADM) tissue that is used primarily in breast reconstruction, is likely […]
Perrigo Recovery Will Happen, Expected to Take Time
Research Question: Will Perrigo recover from a recent string of negative developments to see growth over the short and long term in its three main business lines? Companies: GSK, JNJ, MYL, PRGO, TEVA By: David Franklin Click here to download the report (.pdf) Summary of Findings Perrigo Co. plc (PRGO) is expected to recover over time […]
Perrigo Idea Proposal
Will Perrigo recover from a recent string of negative developments to see short and long term growth in its three main business lines? Report Available: June 10, 2016 Blueshift’s initial research shows uncertainty in the quality of PRGO’s business and their long term trajectory. The company pre-announced Q1 earnings and revenue below Street expectations […]
Novadaq Idea Proposal
Will Novadaq successfully grow DermACELL sales to $50 million or more by 2018? Report Available: June 23, 2016 Blueshift’s initial research shows sales of NVDQ’s DermACELL, its acellular dermal matrix (ADM) product used primarily in breast reconstruction, increasing as it becomes part of the company’s fastest growing segment. Management expects it to reach about $10 […]
Copyright © 2015 Blueshift Research, LLC. All rights reserved.
Connect with Us!